Scientech Research LLC’s Whitehawk Therapeutics WHWK Stock Holding History

Scientech Research LLC’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49.6K	Buy	+10,838	New	+$45.1K	0.04%	196

Other funds holding WHWK

Yu Fan $108M AUM 137.54% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

KVP Capital Advisors San Francisco, California $136M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Scientech Research LLC's WHWK Position: Q2 2026 in Review

Scientech Research LLC opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 10,838 shares worth $49.6K. The stake represents 0.04% of the portfolio and ranks #196 among its holdings.

78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

Scientech Research LLC held 10,838 shares of Whitehawk Therapeutics worth $49.6K as of Q2 2026.
Whitehawk Therapeutics was a new Scientech Research LLC position in Q2 2026.
Whitehawk Therapeutics made up 0.04% of Scientech Research LLC's portfolio in Q2 2026, its #196 holding.
78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.